The emergence of GLP-1 based medications is not just a medical or pharmaceutical phenomenon. It is increasingly an economic phenomenon with profound implications for the consumer goods sector. For decades, the FMCG universe was structured around a simple assumption: growing through increasing consumption occasions. However, what these...